1 / 18

Turning  Cro into a Transcriptional Activator

Turning  Cro into a Transcriptional Activator. Fred Bushman and Mark Ptashne Cell (1988) 54: 191-197. Presented by Drew Endy and Natalie Kuldell for 20.902/20.947 February 6th, 2008. Small patch of acidic residues is necessary and sufficient for transcriptional activation. Figure 1.

indiac
Download Presentation

Turning  Cro into a Transcriptional Activator

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Turning  Cro into a Transcriptional Activator Fred Bushman and Mark Ptashne Cell (1988) 54:191-197 Presented by Drew Endy and Natalie Kuldell for 20.902/20.947 February 6th, 2008

  2. Small patch of acidic residues is necessary and sufficient for transcriptional activation Figure 1 cI normally activates transcription cro normally represses transcription cro/cI chimera activates transcription!

  3. Site-directed mutagenesis of cro helix to make acidic patch cartoon ofcI binding DNA Figure 2 Thr17 Lys21 Asp22 Tyr26 fig from “A Genetic Switch” 4 amino acid substitution --> “cro67”

  4. Why might this work?

  5. Site-directed mutagenesis of cro helix to make acidic patch Figure 2 Thr17 Lys21 Asp22 Tyr26 4 amino acid substitution --> “cro67”

  6. Site-directed mutagenesis of cro helix to make acidic patch Figure 2 Thr17 Lys21 Asp22 Tyr26 4 amino acid substitution --> “cro67”

  7. Site-directed mutagenesis of cro helix to make acidic patch Figure 2 Thr17 Lys21 Asp22 Tyr26 4 amino acid substitution --> “cro67”

  8. Site-directed mutagenesis of cro helix to make acidic patch Figure 2 Thr17 Lys21 Asp22 Tyr26 4 amino acid substitution --> “cro67”

  9. Protein -helix recognizes sequence in DNA major groove model of lac repressor binding lac operator http://www.bact.wisc.edu/Microtextbook/index.php?module=Book&func=displaychapter&chap_id=35&theme=printer

  10. Protein -helix recognizes sequence in DNA major groove • Wild type cro • binds OR3>>OR2 = OR1 • binding to OR3 shuts off tx’n from PRM • Wild type cI • binds OR1>OR2>OR3 • binding to OR2 activates tx’n from PRM

  11. OR1>OR2>OR3 Figure 3 Protein -helix recognizes sequence in DNA major groove • Wild type cro • binds OR3>>OR2 = OR1 • binding to OR3 shuts off tx’n from PRM • Wild type cI • binds OR1>OR2>OR3 • binding to OR2 activates tx’n from PRM • cro67 • binds? • activates?

  12. OR1=OR2>OR3 Figure 3 Protein -helix recognizes sequence in DNA major groove • Wild type cro • binds OR3>>OR2 = OR1 • binding to OR3 shuts off tx’n from PRM • Wild type cI • binds OR1>OR2>OR3 • binding to OR2 activates tx’n from PRM • cro67 • binds? • activates?

  13. 395 bases 250 bases cro67 activates transcription in vitro Figure 4 [cro67] 0 In vitro tx’n rxn’s + buffer + DNA w/ PRM + PR cro67 (purified) + 32P-ATP, CTP, GTP or UTP 37° 10’ then + RNAP 37° 10’ then +formamide to gel

  14. ~5x 395 bases ~5x 250 bases cro67 activates transcription in vitro Figure 4 cut out bands and count Observe: txn of PR as txn of PRM when cro67 added Q’s: What are extra bands? Is cro67 bound in natural way?

  15. OR1=OR2>OR3 cro67 binds operator sequences as expected Figure 4 [cro67] 0 DNase footprint + buffer + 32P-DNA w/ PRM + PR cro67 (purified) 37° 10’? then + DNase 37° 10’? then +formamide to gel? Observe: Q: is assay sensitive to different conformations of bound prot?

  16. cro67 activates transcription in vitro Supporting data/controls Figure 5 Wild type cro does not activate txn in vitro using in vitro txn rxn, DNase ftpt Figure 6 cro67 does not activate txn from other promoters cro67 in vivo exp’ts hampered by low affinity for operators (~100x < wt cro)

  17. Summary of 434 cI data ** in vivo (-gal assays on lysogen) **in vivo DMS ftpt ** in vitro txn rxns, DNase ftpt

  18. Turning cro into a transcriptional activator key assumption in vitro conclusions have meaning in vivo biggest mistake INKHO: mixing the 434 work in IDEHO: not pushing in vivo work significance/meta-lessons • protein engineering by analogy (cro is like cI, thus…) • small changes (e.g., individual AAs) are important • good data enables thoughtful experiments • be open to surprises (e.g., DNA binding) • ask the next question: does activation work the same way in eukaryotic cells?

More Related